Methoden zur vergleichenden Bewertung pharmazeutischer Produkte

@inproceedings{Zentner2005MethodenZV,
  title={Methoden zur vergleichenden Bewertung pharmazeutischer Produkte},
  author={Annette Zentner and Reinhard Busse},
  year={2005}
}
IGWiG) was established in 2004 to, among other tasks, evaluate the benefit of pharmaceuticals. In this context it is of importance that patented pharmaceuticals are only excluded from the reference pricing system if they offer a therapeutic improvement. The institute is commissionedby the FederalJoint Committee (Gemeinsamer Bundesausschuss, G-BA) or by the Ministry of Health and Social 

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

International standards for health economic evaluation with a focus on the German approach.

  • Journal of clinical pharmacy and therapeutics
  • 2013
VIEW 5 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

Health Care Systems in Transition: Germany

R Busse, A. Riesberg
  • Kopenhagen
  • 2004

New Zealand Pharmaceutical Pricing and Reimbursement Policies. LSE Study on Healthcare in individual Countries

R Braae, M Sanidas, N. Thomas
  • Worldwide Survey on Pharmaceutical Pricing and Reimbursement Structures
  • 2002

La commission de la transparence: de l'évaluation à la réévaluation

Bergmann, JF
  • La Presse medicale
  • 2001
VIEW 1 EXCERPT

Pharmaceutical pricing and reimbursement in Spain

  • The European Journal of Health Economics (HEPAC)
  • 2001
VIEW 1 EXCERPT